Nurix Therapeutics (NASDAQ:NRIX) Price Target Cut to $25.00 by Analysts at Wells Fargo & Company
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective dropped by investment analysts at Wells Fargo & Company from $32.00 to $25.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 183.77% from the […]
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective dropped by investment analysts at Wells Fargo & Company from $32.00 to $25.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 183.77% from the […]